Call for Abstract
Scientific Program
2nd International Conference on Clinical & Cellular Immunology, will be organized around the theme “Disseminating the New Trends in Immunology ”
Immunology Summit-2013 is comprised of 17 tracks and 116 sessions designed to offer comprehensive sessions that address current issues in Immunology Summit-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Infection, allergies and immune response
- Track 1-2Chemical signals and pathways in immune system
- Track 1-3Veterinary immunology
- Track 1-4Host defense mechanisms: Humans, animals, prokaryotes and invertebrates
- Track 1-5Clinical immunomics
- Track 1-6Innate immunity, metabolism, and immunology
- Track 1-7Platelet immunology
- Track 1-8Immuno-informatics
- Track 2-1Molecular pathways for human natural killer cells
- Track 2-2Structural and functional parameters of antimicrobial peptides (AMPs)
- Track 2-3Pathogenesis of diseases
- Track 2-4Innate-adaptive interactions
- Track 2-5Approaches to study innate immunity
- Track 2-6Advancing against asthma
- Track 3-1 Autoimmune diseases: Organ and tissue
- Track 3-2Major histocompatibility complex classes
- Track 3-3Role of Th17 cells and their importance
- Track 3-4 Gastro intestinal autoimmunity, skin and autoimmunity
- Track 3-5Systemic lupus erythematosus
- Track 3-6Immune responses in arthritis
- Track 3-7Infection and autoimmunity, and metabolic disorders
- Track 3-8Multiple sclerosis, and mislenious autoimmune diseases
- Track 3-9Inflammatory bowel disease
- Track 4-1Stem cell therapy
- Track 4-2Alternative targets for immunointervention
- Track 4-3Clinical strategies to induce transplantation tolerance
- Track 4-4Immunomodulation and drug discovery
- Track 4-5Stem cell therapy, and soluble mediators and signaling
- Track 4-6Induced immunosuppression therapy and cellular mechanisms
- Track 4-7Immunotherapies and rheumatoid arthritis
- Track 5-1Hepatitis
- Track 5-2Tuberculosis
- Track 5-3Influenza
- Track 5-4HIV/AIDS and Chagas disease
- Track 5-5Malaria
- Track 5-6Human papilloma virus
- Track 5-7 Diabetes
- Track 6-1Tumorigenesis and tumor suppression or cancer immune prevention
- Track 6-2Epithelial stem cell cancer
- Track 6-3Interplay of cancer stem cells and metastasis
- Track 6-4Advances in imaging and detection of cancer stem cells and metastatic precursors
- Track 6-5Model studies for hematopoietic microenvironments
- Track 6-6Genetic and epigenetic regulation of cancer cells
- Track 6-7Cancer surveillance : Metastasis and cancer therapy
- Track 6-8Apoptosis and current research
- Track 7-1 Recombinant vaccines and immunotherapeutics
- Track 7-2Cancer vaccines
- Track 7-3Bacterial and viral vaccines
- Track 7-4Immunological adjuvants
- Track 7-5T-Cell vaccines
- Track 7-6Synthetic vaccines, and contraceptive vaccines
- Track 7-7Vaccine safety
- Track 7-8Anti-inflammatory drugs and antiretroviral therapy
- Track 8-1Osteoimmunology
- Track 8-2Nano-medicine immunology
- Track 8-3Mucosal immunology and translational immunology
- Track 8-4Autophagy in immune regulation
- Track 8-5Immune tolerance in pregnancy
- Track 8-6Testicular immunology
- Track 8-7Immunocontraception
- Track 9-1RISET biomarkers
- Track 9-2ITN biomarkers
- Track 9-3Hybridoma technology
- Track 9-4Assays for immunology
- Track 9-5 Immunophenotyping: Flow cytometry and immunoelectrophoresis
- Track 9-6Biomarkers and immune-modulating therapies
- Track 9-7ITN biomarkers, and immunological biomarkers of tuberculosis
- Track 10-1Immune system regulation
- Track 10-2Transplantational immunology
- Track 10-3Immune rejection: Novel therapeutic targets
- Track 10-4Transplantation: Genetics and HLA system
- Track 10-5Prolonging graft survival: Immunosuppressive drugs and research
- Track 10-6Molecular signatures of tolerance : Islet transplantation
- Track 10-7Memory T cell responses
- Track 11-1Ethical issues in immunology: Alternatives to animals
- Track 11-2Importance of the use of animals in immunological research and drug development
- Track 11-3Other moral issues in immunological research
- Track 11-4Current legislation on clinical research trials
- Track 11-5Medical and comparative ethics
- Track 12-1Neuroimmunological disorders
- Track 12-2Acute disseminated encephalomyelitis
- Track 12-3Multiple sclerosis, neuromyelitis optica and transverse myelitis
- Track 12-4Neurodegenerative disorders
- Track 12-5Neurodevelopmental disorders
- Track 12-6Neural stem cell fate
- Track 12-7Epigenetics of neuroimmunology
- Track 12-8Cell death and immunity
- Track 13-1Therapeutic applications of cytokines and chemokines
- Track 13-2Cytokines and metabolism
- Track 13-3Cytokines in health and disease
- Track 13-4Mucosal homeostasis and inflammation
- Track 13-5The interferons, growth factors, and TNF family
- Track 13-6Hematopoietic growth factors
- Track 13-7Interleukins: TIR-receptor families
- Track 13-8Recently discovered cytokines
- Track 13-9Common cytokine receptor gamma-chain cytokine family
- Track 14-1Pediatric allergy and current research
- Track 14-2Food allergy: Allergens and environmental factors
- Track 14-3Genetic basis
- Track 14-4Diagnosis and pathophysiology
- Track 15-1Molecular aspects of primary immunodeficiency
- Track 15-2Autoimmunity in primary immunodeficiency
- Track 15-3Humoral immune deficiency
- Track 15-4T cell deficiency, differentiation and plasticity
- Track 15-5Complement deficiency
- Track 15-6Neutropenia and asplenia
- Track 16-1Antibiotics and immune system
- Track 16-2Infectious diseases and Medicine
- Track 16-3Immuno suppressive drugs
- Track 16-4Immune rejection
- Track 17-1Rheumatoid arthritis and osteoarthritis
- Track 17-2 New approaches in rheumatology therapy
- Track 17-3Juvenile idiopathic arthritis
- Track 17-4Osteoporosis in rheumatology
- Track 17-5Disease modifying anti-rheumatic drugs (DMARDs)
- Track 17-6 Use of glucocorticoids and NSAIDs in rheumatic diseases